Close Menu

IPO

NEW YORK (GenomeWeb) – Melanoma test development firm DermTech International has filed to go public with a proposed offering of up to $25 million in stock.

NEW YORK (GenomeWeb) – Ariosa Diagnostics has priced its planned initial public offering of 3.5 million shares.

NEW YORK (GenomeWeb News) – Ariosa Diagnostics has filed a regulatory document with the US Securities and Exchange Commission for an initial public offering.

NEW YORK (GenomeWeb News) – French molecular diagnostics company Genomic Vision today announced the launch of its initial public offering.

Startup Microlin Bio last week revealed that it is aiming to price shares in its planned initial public offering at between $6 and $8 apiece.
The company did not provide any details regarding the expected timing of the transaction.

NEW YORK (GenomeWeb News) – Biocept said after the close of the market on Monday that it has closed its initial public offering, raising $19 million in gross proceeds.

NEW YORK (GenomeWeb News) – Biocept today went public as shares of its common stock began trading at $10, the low end of an anticipated price range on its initial public offering.

Dicerna Pharmaceuticals this week priced its initial public offering of 6 million shares of its common stock at $15 a share — higher than the $13 to $15 range it had previously projected.

Just months after securing the rights to its core intellectual property, microRNA shop Microlin Bio has filed with US regulators for a $25 million initial public offering.

In breaking out its pipeline in detail for the first time as it looks to go public, Dicerna Pharmaceuticals revealed that it is following along with others in the RNAi therapeutics field, namely Alny

Pages

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.